Quantum Biopharma QNTM
NASDAQ QNTM
$3.44 +0.02 (+0.58%)
At close: Oct 2, 2026 · 4:00 PM EDT

Quantum Biopharma (QNTM) Asset Writedowns and Impairment (2020 - 2023)

Updated

Quantum Biopharma's Asset Writedowns and Impairment came in at $236,186 for Q4 2023.

Analysis

Quantum Biopharma (QNTM) Asset Writedowns and Impairment (2020 - 2023) Analysis & Trends

For FY2023, Quantum Biopharma's Asset Writedowns and Impairment was $4.56 million.

  • Asset Writedowns and Impairment carries a four-year compound annual growth rate of 123.3% (FY2019 to FY2023).
  • Going back by year, Asset Writedowns and Impairment was $89,860 in FY2020 (-50.9%) and $183,161 in FY2019.
  • The Q4 2023 figure represents the lowest quarterly Asset Writedowns and Impairment since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Quantum Biopharma 13.37 Mn 1.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 236,186.00
Jun 30, 2023 3.84 Mn
Mar 31, 2023 480,096.00
Dec 31, 2021 89,860.00
Mar 31, 2021 -89,860.00
Mar 31, 2020 89,860.00
API Access

Quantum Biopharma Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=QNTM&period=max&api_key=YOUR_API_KEY